Pseudophakia Clinical Trial
Official title:
Intermediate Vision in a Driving Simulator Environment: Comparison of the New J&J EYHANCE IOL With a Conventional Monofocal IOL
To compare (low contrast) visual acuity (VA) and contrast sensitivity (CS) - both at
intermediate distances under nighttime driving conditions in a driving simulator between
patients with bilateral EYHANCE IOLs OR bilateral conventional monofocal IOLs. Visual
function testing in the driving simulator will be assessed without AND with (static) glare.
Additionally: Assessment of individual response times, scanpath characteristics, evaluation
of test retest reliability and self-evaluation of (intermediate) vision and visual impairment
related to glare.
To compare (low contrast) visual acuity (VA) and contrast sensitivity (CS) - both at
intermediate distances under nighttime driving conditions in a driving simulator between
patients with bilateral EYHANCE IOLs OR bilateral conventional monofocal IOLs. Visual
function testing in the driving simulator will be assessed without AND with (static) glare.
Additionally: Assessment of individual response times, scanpath characteristics, evaluation
of test retest reliability and self-evaluation of (intermediate) vision and visual impairment
related to glare.
Simulator
Patients are instructed to drive with a constant speed of 40 km/h on a virtual parcours
(straight lane). For testing of either (low contrast) visual acuity or contrast sensitivity,
8-position LANDOLT C's are presented at three locations (within the simulator car, AUDI A4,
Ingolstadt/FRG):
(i) At the center of the instrument panel (distance 0.xx m) (ii) At the center of the
navigation monitor (y.yy m) (iii) At the center of the rear monitor (z.zz m) A high
resolution acoustic attention guidance for immediate gaze direction of the patients towards
the three above-mentioned visual stimulus locations (i-iii) is mandatory.
Patients responses are recorded and response times can be extracted from the recordings.
Clinical ophthalmological-optical examinations
- Medical/ophthalmological history
- (Uncorrected and Best-corrected) visual acuity (RE,LE,BE) with remote and intermediate
(66cm) 8 position LANDOLT C's.
- LANG I stereotest (near distance)
- Ocular alignment & ocular motility
- Efferent & afferent pupillomotor status
- Mesopic contrast sensitivity without/with glare (Optovist, VISTEC Inc./Olching/FRG)
- Intraocular straylight perception (Q-Quant, OCULUS Inc, Wetzlar/FRG)
- Slit lamp (anterior segment)
- Ophthalmoscope (central fundus and fixation)
- Primary objectives: log visual acuity (logVA) at preset low contrast level of 1:2.7
(logCS = 0.2) AND log contrast sensitivity (logCS) at a preset visual acuity level
of 0.1 = 2/20)
- Secondary objectives: test retest reliability (as operationalized by LOA = limits
of agreement) AND response time (i.e. time interval between onset of stimulus
presentation and final response) AND scanpath characteristics (fixation duration,
fixation stability, annotation to regions of interest; saccade amplitude)
self-evaluation (questionnaire, using visual analogue scales = VAS)
SHAPIRO WILK test (statistical testing for proving/disproving normal distribution)
Descriptive statistics (either MEAN, standard deviation, in case of normally distributed data
- else, MEDIAN, inter-quartile range (IQR).
Assessment of test/retest reliability: BLAND ALTMAN plots, limits of agreement (LOA)
Between-group comparison: t-test (unpaired samples), in case of normally distributed data -
else, WILCOXON signed-rank test
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01193504 -
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
|
Phase 4 | |
Completed |
NCT00347243 -
Wavefront Analisys and Contrast Sensitivity of Spherical and Aspherical Intraocular Lenses
|
Phase 4 | |
Completed |
NCT04208633 -
Correlation Between Sulcus Anatomy and Other Parameters After Horizontal & Vertical Intraocular Lens (IOLs) Placements
|
N/A | |
Recruiting |
NCT06041139 -
Visual Outcomes and Patient Satisfaction With Bilateral PanOptix Verses Bilateral Synergy
|
||
Completed |
NCT04533191 -
Binocular Custom Vision Utilizing The Light Adjustable Lens (LAL)
|
||
Completed |
NCT05735990 -
Retrospective Clinical Investigation of the Safety and Performance of 640PM Trifocal IOL Implantation in Patients With Cataract and/or Ametropia (Hyperopia, Myopia) and/or Presbyopia
|
||
Recruiting |
NCT04175951 -
Tecnis Eyhance Versus Rayner RayOne Study
|
N/A | |
Not yet recruiting |
NCT06056154 -
Safety and Efficacy of the Hydrophobic Intraocular Lens AsqelioTM Monofocal With Biaspheric Design
|
||
Not yet recruiting |
NCT05531110 -
Comparison of Two Aspheric Intraocular Lenses for Micro-monovision
|
N/A | |
Completed |
NCT01004549 -
An Open-Label Evaluation of Degree of Accommodation in Pseudophakic Patients Bilaterally Implanted With Monofocal Intraocular Lenses
|
N/A | |
Recruiting |
NCT03823092 -
Polarization Perception in Health and Disease. Testing a New Sight Test
|
||
Completed |
NCT05226884 -
Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs
|
||
Completed |
NCT01310127 -
Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%
|
Phase 4 | |
Completed |
NCT05335408 -
Evaluation of Visual Function After Bilateral Implantation of EDOF IOLs
|
N/A | |
Completed |
NCT05611073 -
Maximizing Visual Outcomes With Eyhance IOLs
|
||
Completed |
NCT04319497 -
Subjective and Objective Refraction in Pseudophakic Patients
|
N/A | |
Completed |
NCT05418153 -
Synergy Lens Outcomes Evaluation
|
||
Recruiting |
NCT06065072 -
Comparative Study of the Tomey OA-2000, Tomey CASIA2, and the LenStar LS900
|
||
Completed |
NCT02450799 -
Corrected VA With Long-Term Follow-Up After AcrySof® Intraocular Lens (IOL) Implantation
|
N/A | |
Completed |
NCT00428363 -
Effect of Optic Edge Design in a Silicone Intraocular Lens on Posterior Capsule Opacification
|
Phase 4 |